Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Kids as young as 6 years old could soon be allowed access to a weight loss drug, similar to Ozempic, to help reduce obesity.

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6-11, according to research presented Sept. 10 at a medical conference and published in the New England ...

Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to produce ...

With so many kids already taking weight loss injectables like Ozempic, a new finding from the company behind the blockbuster ...